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LETTERS TO THE EDITORS
Bat Rabies Virus
Variants Causing
Human Rabies
To the Editors:
Willoughby and Hammarin1 haverecently discussed human rabies
caused by bat rabies virus variants. They
stated “the colonial species of bats
found in very large numbers under
bridges and in caves in central Texas
have not transmitted rabies to humans.”
The main bat species they are referring
to is the Brazilian (Mexican) free-tailed
bat, Tadarida brasiliensis, and the ra-
bies virus variant associated with this
species is actually second only to the
variant associated with Lasionycteris
noctivagans (silver-haired bat) and Pip-
istrellus subflavus (eastern pipistrelle
bat) as the most common cause of hu-
man rabies in the United States. Since
1990, there have been 7 well-documented
fatal cases of human rabies resulting
from infection with this variant in Texas
(1990), Alabama (1994), California
(1995, 2000 and 2002), Georgia (2000)
and Arkansas (2004).2,3 The latter case
was an organ donor in Texas, and trans-
mission occurred to 4 transplant recipients
with fatal outcomes.4 Although rabies is
very common in big brown bats (Epte-
sicus fuscus), the variant associated with
these bats is a rare cause of fatal human
rabies, and a case occurred in Washing-
ton in 1997.2 Little brown bats (Myotis
lucifugus) belong to the Myotis species,
and variants associated with this genus
have also caused fatal human rabies in
Washington in 19952 and in British Co-
lumbia in 2003.5
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Ptosis as a Presenting
Feature of Bacterial
Meningitis
To the Editors:
Involvement of the cranial nerves as apresenting feature of bacterial menin-
gitis is rare.1–3 We report a case present-
ing with total right oculomotor nerve
palsy (OMP) caused by Streptococcus
pneumoniae meningitis.
An 8-month-old boy was brought
to the emergency department of the
Children’s Hospital Medical Center, Te-
hran, Iran, with abrupt onset of ptosis of
the right eye. He had been well until 3
days earlier, when he developed fever
and restlessness. The infant was diag-
nosed at that time as having otitis and
managed as an outpatient with prometh-
azine and oral antibiotics. On the day of
admission, he was afebrile and alert but
appeared ill. The anterior fontanel was
flat. He had a complete right side ptosis
with a dilated pupil that was unrespon-
sive to light. The eyeball deviated later-
ally and inferiorly. A brain computer-
ized tomographic scan revealed no
pathologic findings. Lumbar puncture
was done which showed turbid cerebro-
spinal fluid. The cerebrospinal fluid
smear and culture were positive for S.
pneumoniae, along with 110 white
blood cells/mm3 (85% polymorphonu-
clear cells, 15% lymphocytes), 1 mg/
100 mL glucose and 290 mg/100 mL
protein. Intravenous ceftriaxone, vanco-
mycin and dexamethasone were started
without further delay. He developed a
low grade fever for 2 days coupled with
left facial nerve palsy, poor feeding,
several attacks of seizure along with
ptosis and mydriasis on the left side and
a gradual decrease in the level of con-
sciousness leading to coma. A second
brain computerized tomographic scan
confirmed multiple hypodense regions
in the basal ganglia, the thalamus and
the internal capsule. A second lumbar
puncture was performed which showed
a good response to antibiotics with 23
white blood cells/mm3, 52 mg /100 mL
glucose, 97 mg/100 mL protein and a
negative smear and culture. The clinical
condition of the patient continued to
deteriorate, leading to severe spasticity
and apnea. The infant died 7 days after
the day of admission. Postmortem study
was not permitted by the parents.
OMP can result from intraorbital,
intracranial or systemic infections,2 in-
cluding meningitis. Acute bacterial
meningitis is a well-known cause of
acute palsies of either the seventh or the
eighth cranial nerve4 but uncommonly
produces acute onset palsy of oculomo-
tor nerve, especially as a presenting
symptom of the disease. In most of the
reported cases for cranial nerve palsy, it
has been a sequela of the infectious
process and not a presenting feature.1–3
The mechanisms of oculomotor
palsy in this patient could have been the
inflammation around the nerve, but be-
cause of its acute nature a vascular
mechanism (vasculitis or thrombosis of
the small penetrating arteries) may be
the likely cause of this unusual presen-
tation.
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Septic Shock
Complicating Acute
Rotavirus-Associated
Diarrhea
To the Editors:
Even though enteric Gram-negativerod (EGNR) bacteremia has been de-
scribed as a possible complication of
acute gastroenteritis,1,2 very few reports
of EGNR bacteremia as a complication
of rotavirus-associated acute diarrhea
have been published to date.3 Herein we
report 1 case of acute rotavirus-associ-
ated diarrheal disease complicated by
enteric Gram-negative-induced sepsis
and septic shock.
A previously healthy 10-month-
old female infant was admitted after
presenting watery diarrhea, heavy vom-
iting and low grade fever for 24
hours. At physical examination, leth-
argy, tented skin, dry mucous mem-
branes, sunken eyes and delayed cap-
illary refill were noted. White blood
cells (WBC) count was normal except
for mild lymphocytosis. Arterial blood
gas, serum electrolytes, liver and renal
function tests, urine and stool analysis and
stool culture were normal. Enzyme immu-
noassay of stool samples was positive for
rotavirus. Intravenous fluids were started,
and the infant’s condition improved on the
following day.
On the third postadmission day,
she appeared lethargic and presented fe-
ver (39.1°C), tachycardia (180 beats/
min), tachypnea (50 respirations/min),
poor peripheral perfusion, disseminated
dark papulae in the skin and oliguria.
Arterial hypotension (63/44 mm Hg)
and severe metabolic acidosis (arterial
blood pH, 7.24; bicarbonate, 9 mmol/L)
ensued. A new WBC count revealed 10%
band forms; platelets, 290,000/mm3. She
was admitted to the intensive care unit,
and aggressive fluid resuscitation and
norepinephrine were started. Cerebro-
spinal fluid analysis was normal. Empir-
ical antimicrobial therapy was started
with cefepime. She developed dissemi-
nated intravascular coagulation (DIC)
(platelets, 51,000/mm3; prothrombin ac-
tivity, 20%; activated partial thrombo-
plastin time, 180 s) and, despite the
prophylactic use of omeprazole and the
transfusion of platelets and fresh frozen
plasma, she presented a self-limited up-
per gastrointestinal hemorrhage. No sei-
zures occurred. A blood culture isolated
a multidrug-resistant extended spectrum
-lactamase (ESBL)-producing Esche-
richia coli strain (resistant to ampicil-
lin, ampicillin  sulbactam, aztreonam,
cephalothin, cefazolin, cefepime, cefta-
zidime, ceftriaxone and cefuroxime).
Antimicrobial therapy was then changed
to meropenem. On the third day of in-
tensive care unit stay, cellulitis was
noted on her left leg. A new WBC count
revealed 34,600 cells/mm3, with 20%
band forms and 2% metamyelocytes.
Culture of the cellulitis purulent secre-
tion yielded multidrug-resistant ESBL-
producing E. coli. Antimicrobial therapy
was maintained and the celullitis re-
solved in 5 days. She completed a 14-
day regimen of meropenem and was
discharged home. Liver and renal func-
tion tests remained normal throughout
the hospital stay. She appeared to be in
excellent health on the follow-up visit 1
month later.
Dehydration and hypovolemic shock
are regarded as the most severe end of
the spectrum of rotaviral disease. Our
young infant was admitted because of a
severe dehydrating typical rotaviral di-
arrhea that improved with supportive
management; she deteriorated abruptly
3 days after the onset of the disease,
developing lethargy and clinical and
laboratory signs of systemic inflamma-
tory response. A blood culture con-
firmed bloodstream infection, thus seal-
ing the diagnosis of EGNR-induced
sepsis. A multidrug-resistant ESBL-pro-
ducing E. coli was isolated, and the em-
pirical antimicrobial regimen adopted was
ineffective. Consequently the patient de-
teriorated and developed severe compli-
cations of sepsis and shock, DIC and
upper digestive bleeding.
Although severe sepsis, especially
with Gram-negative bacteria, is the main
cause of DIC in children, shock of any
etiology can lead to DIC. DIC has
been reported in infants with rotavirus
diarrhea and negative blood cultures,4
presumably as a consequence of hy-
povolemic shock and its metabolic de-
rangements, but a direct effect of vire-
mia cannot be excluded.
The precise mechanisms by which
normal intestinal flora bacteria reach the
bloodstream and spread throughout the
body remain unclear. Although it is
tempting to believe that normal intesti-
nal flora disseminate through a damaged
mucosa during rotaviral disease, rotavi-
rus has never been shown to cause sub-
stantial cell death or mucosal inflamma-
tion.5,6 On the other hand, rotavirus is
known to cause intestinal epithelium
dysfunction, and rotavirus-infected en-
terocytes are more vulnerable to bacte-
rial invasion.7 The impact of these
findings on intestinal permeability to
bacteria from normal intestinal flora is
unknown.
The case herein presented docu-
ments a life-threatening complication
of rotavirus-associated diarrhea that is
rarely reported. Although it may indeed
be a rare event, it may also be frequently
overlooked and confused with a severe
picture caused by rotavirus alone. The
possibility of sepsis should be promptly
considered in severely ill patients and
in those who develop lethargy, poor
peripheral perfusion or signs of sys-
temic inflammatory response after a few
days with proven or suspected rotaviral
diarrhea.
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Oseltamivir and
Delirious Behavior in
Children With Influenza
To the Editors:
Influenza virus sometimes causes se-vere disease including pneumonia,
bronchiolitis and encephalopathy. A
substantial number of influenza-associ-
ated deaths occur even in advanced
countries. In addition, there is an in-
creasing threat of pandemic avian influ-
enza virus disease that can have a high
case fatality rate.1 The neuraminidase
inhibitor oseltamivir constitutes an im-
portant treatment option for influenza.
Moreover many countries have begun to
stockpile oseltamivir as a part of their
pandemic planning. Oseltamivir has few
adverse effects when administered for
either treatment or prophylaxis,2 al-
though the safety of oseltamivir in in-
fants has not been established.3 More-
over some pediatric deaths after the use
of oseltamivir were recently reported in
Japan. Among them, the concern arose
that abnormal behavior in relation to
oseltamivir may have resulted in acci-
dental deaths of 2 juvenile patients (re-
ported by Hama).4
We studied retrospectively the oc-
currence of delirious behavior after the
use of oseltamivir in pediatric patients.
The records of patients younger than 15
years of age who were prescribed oselta-
mivir between January 2004 and March
2005 were reviewed in 6 Nagoya Univer-
sity-affiliated hospitals. We included all
patients with documented influenza who
had delirious behavior during this period
whether or not they were treated with
oseltamivir.
Oseltamivir was prescribed to
6121 patients in the 6 hospitals. Nine
patients with delirious behavior were
identified, of whom 4 patients (2 boys
and 2 girls) had delirious behavior after
the use of oseltamivir. The average age
of these 4 patients was 5.9 years (range,
3.7–10.1 years). Delirious behavior was
observed 1 day after the onset of fever in
all patients. Its duration was 30 minutes
or less in 2 patients, but it lasted inter-
mittently for several hours in the other 2.
Their delirious behavior included mean-
ingless speech, disorientation, fearful re-
sponse and running around the room. No
patient had neurologic sequelae.
From the review of their medical
records, we believe that oseltamivir was
not responsible for delirious behavior in
these 4 patients. All patients received
other drugs including antipyretics and
antihistamine drugs that can cause ad-
verse effects with neurologic findings.
All patients received additional doses of
oseltamivir despite the delirious behav-
ior, which did not recur in any of them.
The result of our review is consis-
tent with the statement of the United
States Food and Drug Administration on
the safety of oseltamivir.5 We totally
agree with the comment from United
States Food and Drug Administration
that the increased reports of neuropsy-
chiatric events in Japanese children are
most likely caused by an increased
awareness of influenza-associated en-
cephalopathy, increased access to osel-
tamivir and a coincident period of inten-
sive monitoring of adverse events.
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Anthrax
Meningoencephalitis
Secondary to Oral
Infection
To the Editors:
Meningeal involvement is an extremelyrare manifestation of anthrax, and
most cases are secondary to gastrointesti-
nal and mediastinal infection.1 We report
fatal anthrax meningitis that developed
following oral anthrax disease.
An 11-year-old boy from a highland
village of eastern Turkey had a few small,
itchy papules on the oral surface of his lips
with high fever, headache and sore throat
on January 22, 2006. Within4–6 hours,
his lips and tongue became swollen, and
dysphonia developed. When he was ad-
mitted to our pediatric emergency clinic,
he was unconscious with shallow breath-
ing caused by oropharyngeal edema. The
patient had 3 generalized seizures and was
mechanically ventilated because of apnea
episodes.
Edema of his tongue and lips with
widespread, small, necrotic vesicular le-
sions, chills, nuchal rigidity and a positive
Kernig-Brudzinski sign were the most
significant findings. Vital signs were:
fever 36°C (rectal), blood pressure 88/60
mm Hg and heart rate 92/min.
Hematologic findings included white
blood cell count of 18,700/mL with 85%
neutrophils and 9% lymphocytes. Erythro-
cyte sedimentation rate was 3 mm/h. The
cerebrospinal fluid (CSF) findings were
glucose 117 mg/dL (simultaneous serum
155 mg/dL), protein 439 mg/L and chlo-
ride 102 mg/L. Many erythrocytes, 3000
neutrophil/mm3 and 1000 mononuclear
leukocytes/mm3 were present, and Gram
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staining of the CSF also showed the pres-
ence of large (1.5–2  6–8 m in size)
and square-ending Gram-positive bacilli
that appeared single or as chains of 2–3
organisms.
Computerized tomography scan and
radiograph of the chest were normal. Cra-
nial computerized tomography scan dem-
onstrated 5 8 mm of hemorrhagic focus
in the left supratentorial area and diffuse
cerebral edema. Magnetic resonance scan
of the brain revealed findings consistent
with meningoencephalitis in both cerebral
hemispheres, cerebellum and basal gangli-
ons. Therapy was commenced empirically
with acyclovir, cefotaxime and dexameth-
asone. For consideration of anthrax, cip-
rofloxacin was also added to the therapy
(20 mg/kg/d, in 2 equally divided doses).
After an overnight culture of the
CSF sample, white, wavy and nonhemo-
lytic R-form colonies 3–4 mm in diameter
grew on sheep blood agar. Bacterial growth
with similar morphology was observed
from an aerobic blood culture and from
the aspirate of an oral mucosal vesicle.
The organism did not grow in 6% NaCl
containing nutrient agar; was urease-neg-
ative; reduced nitrate; used glucose, mal-
tose and sucrose; and hydrolyzed gelatin.
The organism was susceptible to penicil-
lin, azithromycin, rifampin, clindamycin,
ciprofloxacin and vancomycin by disk dif-
fusion testing. Minimal inhibitory concen-
trations of penicillin and ciprofloxacin
were 0.032 and 0.023 g/mL, respectively.
The organism was identified as Bacillus
anthracis based on growth characteris-
tics, morphologic features, biochemical
reactions and antimicrobial susceptibility
pattern.
The patient’s fevers gradually de-
creased to 34–34.5°C. Disseminated in-
travascular coagulation developed, and
fresh plasma was given 3 times. Phenyt-
oin was commenced for continuing sei-
zures. Pupillary reflexes in both eyes
disappeared, and electroencephalograpy
confirmed brain death 32 hours after
admission. The patient could not be re-
suscitated from a cardiac arrest at 40
hours, and he died on January 25.
Polymerase chain reactions were
conducted for the CSF, blood and vesic-
ular aspirate samples. The pathogen was
confirmed as anthrax bacillus. Polymer-
ase chain reaction testing for herpesvi-
rus was negative for these 3 samples.
There are a few well-documented
case reports of anthrax meningitis in
pediatric patients.2–4 The infections de-
veloped secondary to pneumonia2 or
gastroenteritis3,4 caused by B. anthracis.
Acquisitions of the organism by these
patients resulted from inhalation of the
spores or from ingestion of contami-
nated food. Family infections were also
encountered.3 Hemorrhagic and edema-
tous meningitis and sepsis developed in
all the cases, and only 1 patient recov-
ered from the infection.2–4
A detailed interview was con-
ducted with the patient’s family. They
heard that 4 cattle in their neighbor’s
farm died due to anthrax in the previous
summer. The patient assisted his father
and his neighbors when they processed the
meat during the Muslim Festival of Sac-
rifices on January 10–14. The patient’s
oral lesions emerged within 4 or 5 days.
Anthrax is prevalent in the Middle
East. Though the developed countries
have reduced the prevalence of anthrax
with vaccination practices and industrial
hygiene,5 it is still prevalent in the east-
ern part of the Turkey.
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